Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin

AUTOR(ES)

Moura, Edmilson Bastos de, Maia, Marcelo de Oliveira, Ghazi, Monalisa, Amorim, Fábio Ferreira, Pinhati, Henrique Marconi

FONTE

Braz J Infect Dis

DATA DE PUBLICAÇÃO

2012-10

RESUMO

Disseminated strongyloidiasis is a disease with high mortality rate, especially in immunocompromised individuals. Paralytic ileus and intestinal malabsorption are frequent symptoms caused by this severe disease. As there are no licensed parenteral anthelmintic drugs for human use, off-label formulations are often used in the treatment of this disease. In this case report, the use of subcutaneous ivermectin is described as a successful therapy for this life-threatening infection.

Documentos Relacionados

• Glucocorticoid hypersensitivity in an asthmatic patient: presentation and treatment.
• Hemophagocytic syndrome associated with cytomegalovirus infection in a severely immunocompromised AIDS patient: case report
• Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease
• Recurrent, Disseminated Mycobacterium marinum Infection Caused by the Same Genotypically Defined Strain in an Immunocompromised Patient
• Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis.